Stentys is a medical device company based in Paris that has developed both bare-metal and drug-eluting self-expanding stents to treat coronary heart disease in patients with acute myocardial infarction and/or bifurcations. This technology, which is currently undergoing clinical trials, has the potential to help hundreds of thousands of patients to avoid open heart surgery.